Biggest News Aggregation in the World
📰 Restated Listing Statement News

Page 4 - Restated Listing Statement News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Restated Listing Statement. Real-time updates on events, politics, business and more.

Braxia Scientific CEO to Speak at American Psychiatric Association Annual Meeting on Treatment Resistant Depression and Ketamine Guidelines Published in American Journal of Psychiatry

/PRNewswire/ - Braxia Scientific Corp. ("Braxia Scientific", or the "Company"), (CSE: BRAX) (OTC: BRAXF) (FWB: 4960) is pleased to announce that its CEO, Dr....
United States Roger Mcintyre Rogers Mcintyre American Psychiatric Association Braxia Scientific Corp Excellence Inc

UPDATE - Braxia Scientific Reaches Agreements To Settle Class Actions In US And Canada – InsuranceNewsNet

-Braxia Scientific Corp., announced today that it has reached an agreement in principle to settle claims alleged in a securities class action pending against the Company and certain of its former officers filed in the United States District Court for the Central District of California in April, 2021. The Company also announced it has signed a settlement...
United States United Kingdom Rogers Mcintyre David Greenberg Braxia Scientific Corp United States District Court

Braxia Scientific Reaches Agreements To Settle Class Actions In US And Canada – InsuranceNewsNet

-Braxia Scientific Corp., announced today that it has reached an agreement in principle to settle claims alleged in a securities class action pending against the Company and certain of its former officers filed in the United States District Court for the Central District of California in April, 2021. The Company also announced it has signed a settlement...
United States United Kingdom Rogers Mcintyre David Greenberg Braxia Scientific Corp United States District Court

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Braxia Scientific Reports Q3 2022 Financial Results; Company Leads in Psychedelic Research, Access and Therapist Training with First Multi-Dose Psilocybin Trial in Canada

Achieved milestone with the start of landmark psilocybin clinical trial in Q3 2021- more than a dozen patients receive initial dose to date in first-ever...
Roger Mcintyre Rogers Mcintyre Research Ethics Braxia Scientific Corp Cognition Discovery Foundation Research Database

Braxia Scientific Reports Q3 2022 Financial Results; Company Leads in Psychedelic Research, Access and Therapist Training with First Multi-Dose Psilocybin Trial in Canada

Achieved milestone with the start of landmark psilocybin clinical trial in Q3 2021- more than a dozen patients receive initial dose to date in first-ever...
Roger Mcintyre Rogers Mcintyre Research Ethics Braxia Scientific Corp Cognition Discovery Foundation Research Database

Braxia Scientific Provides Update on Large Proprietary Dataset Expected to Support Pharmaceutical and Industry Clinical Trials for Ketamine and Psilocybin Drug Development

/PRNewswire/ - Braxia Scientific Corp. ("Braxia", or the "Company"), (CSE: BRAX) (OTC: BRAXF) (FWB: 4960), a medical research company with clinics providing...
United States Rogers Mcintyre Roger Mcintyre Canadian Rapid Treatment Centre Of Excellence Braxia Scientific Corp Excellence Inc

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science